文献速递区域麻醉与超声疼痛医学

神经周围与全身地塞米松延长外周神经阻滞镇痛效果的比较:系统评价与Meta分析

Efficacy of perineural vs systemic dexamethasone to prolong analgesia after peripheral nerve block: a systematic review and meta-analysis.
PubMed 文献 · Br J Anaesth · 2017-01-01

该Meta分析纳入11项对照试验共914例患者,比较神经周围与全身地塞米松在外周神经阻滞中的镇痛效果。神经周围地塞米松使镇痛持续时间平均延长3小时(95%CI:1.4-4.5),布比卡因亚组延长21%(4.0小时),罗哌卡因亚组延长12%但无统计学意义。其他次要结局无显著差异,证据质量中等。

要点

  • 神经周围地塞米松较全身用药延长镇痛持续时间约3小时(95%CI:1.4-4.5)。
  • 布比卡因亚组镇痛延长4.0小时(95%CI:2.8-5.2),罗哌卡因亚组无显著差异。
  • 神经周围地塞米松为超说明书用法,需谨慎权衡。

核心结论

  • 中等质量证据表明,与全身地塞米松相比,神经周围地塞米松联合布比卡因可轻度延长镇痛持续时间,但对罗哌卡因无显著影响。
  • 神经周围地塞米松对其他疼痛相关结局无显著影响。

研究设计与样本

  • 系统评价与Meta分析,遵循PRISMA指南,纳入11项对照试验共914例患者。
  • 主要结局为按局麻药类型(布比卡因或罗哌卡因)分析的镇痛持续时间。

主要发现

  • 神经周围地塞米松较全身地塞米松延长镇痛持续时间平均差异3小时(95%CI:1.4-4.5小时;P=0.0001)。
  • 布比卡因亚组镇痛持续时间延长21%(平均差异:4.0小时;95%CI:2.8-5.2小时;P<0.00001)。
  • 罗哌卡因亚组镇痛持续时间延长12%(平均差异:2.0小时;95%CI:-0.5-4.5小时;P=0.11)。
  • 其他次要结局(累积阿片消耗、疼痛评分、并发症率)无显著差异。
  • 未报告神经系统并发症或感染;仅两项试验报告全身地塞米松未升高血糖。

关键数值与推荐

  • 主要结局证据质量按GRADE系统为中等。
  • 镇痛持续时间平均差异3小时(95%CI:1.4-4.5小时;P=0.0001)。
  • 布比卡因亚组平均差异4.0小时(95%CI:2.8-5.2小时;P<0.00001)。
  • 罗哌卡因亚组平均差异2.0小时(95%CI:-0.5-4.5小时;P=0.11)。

临床怎么用

  • 神经周围地塞米松联合布比卡因可考虑用于延长外周神经阻滞镇痛,但需注意超说明书用药。
  • 罗哌卡因联合神经周围地塞米松的获益不显著,应权衡利弊。

局限性

  • 仅两项试验报告血糖结局,证据有限。
  • 主要结局证据质量仅为中等。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

Perineural dexamethasone has gained popularity in regional anaesthesia to prolong the duration of analgesia, but its advantage over systemic administration is disputed. The objective of this meta-analysis was to compare the analgesic efficacy of both routes of administration during peripheral nerve block. The methodology followed the PRISMA statement guidelines. The primary outcome was the duration of analgesia analysed according to the type of local anaesthetic administered (bupivacaine or ropivacaine). Secondary outcomes included cumulative opioid consumption in morphine i.v. equivalents, pain scores, and complication rates (neurological complications, infection, or hyperglycaemia). Eleven controlled trials, including 914 patients, were identified. The duration of analgesia was significantly increased with perineural dexamethasone vs systemic dexamethasone by a mean difference of 3 h [95% confidence interval (CI): 1.4, 4.5 h; P=0.0001]. Subgroup analysis revealed that the duration of analgesia was increased by 21% with bupivacaine (mean difference: 4.0 h; 95% CI: 2.8, 5.2 h; P<0.00001) and 12% with ropivacaine (mean difference: 2.0 h; 95% CI: -0.5, 4.5 h; P=0.11). The quality of evidence for our primary outcome was moderate according to the GRADE system. There were no significant differences in other secondary outcomes. No neurological complications or infections were reported. Glucose concentrations were not increased when dexamethasone was injected systemically, but this outcome was reported by only two trials. There is, therefore, moderate evidence that perineural dexamethasone combined with bupivacaine, but not ropivacaine, slightly prolongs the duration of analgesia, without an impact on other pain-related outcomes, when compared with systemic dexamethasone. Injection of perineural dexamethasone should be cautiously balanced in light of the off-label indication for this route of administration.

来源:Br J Anaesth,查看原文。版权归原作者所有。

引用

  1. Baeriswyl M, Kirkham KR, Jacot-Guillarmod A, et al. Efficacy of perineural vs systemic dexamethasone to prolong analgesia after peripheral nerve block: a systematic review and meta-analysis. Br J Anaesth. 2017. PMID: 28854551. doi:10.1093/bja/aex191

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。